反応式
[CH3:1][C:2]1[C:3]([C:7]([OH:9])=O)=[N:4][O:5][N:6]=1.[NH2:10][C:11]1[CH:12]=[C:13]([CH:16]=[CH:17][CH:18]=1)[C:14]#[N:15].C(N(CC)C(C)C)(C)C>CN(C=O)C.C(Cl)Cl.CN(C1C=CN=CC=1)C>[C:14]([C:13]1[CH:12]=[C:11]([NH:10][C:7]([C:3]2[C:2]([CH3:1])=[N:6][O:5][N:4]=2)=[O:9])[CH:18]=[CH:17][CH:16]=1)#[N:15]参加物
6
反応物 3
生成物 1
試薬・触媒・溶媒 2
実験手順
4-Methyl-1,2,5-oxadiazole-3-carboxylic acid (200 mg, 1.6 mmol) and bromotris(pyrrolydino)phophonium hexafluorophosphate was dissolved in a 1/1 mixture of DMF/DCM. To the mixture was added DMAP (120 mg, 0.95 mmol) and 3-amino-benzonitrile (184 mg, 1.6 mol) followed by N,N-diisopropylethylamine. The reaction mixture was stirred at rt overnight. The volatiles were removed in vacuo and the residue dissolved with chloroform and loaded onto a 40 g Silica ISCO cartridge eluting with 25%-50% EtOAc/Hexane to afford a white powder (25 mg). MF=C11H8N4O2; LCMS calculated for C11H9N4O2(M+H)+: m/z=229.1.
後処理
- customThe volatiles were removed in vacuo
- dissolutionthe residue dissolved with chloroform
- washeluting with 25%-50% EtOAc/Hexane
出典と根拠
- ORDレコード
- ord-77155a5d57f747a5bcec6555903b8f7c
- 出典データセット
- uspto-grants-2013_05
- 特許番号
- US08450351B2
関連ノート
読み込み中…